Q: How does Aflibercept work?

Aflibercept, the active ingredient in Eylea 2 mg, works by binding to vascular endothelial growth factor (VEGF)-A, VEGF-B, and placental growth factor (PlGF). By binding to these factors, Aflibercept prevents the activation of VEGF receptors, thereby inhibiting angiogenesis and reducing vascular permeability. This mechanism helps to prevent the formation of abnormal blood vessels and leakage in the retina, which can lead to vision loss in various eye conditions.

Question 1

What is Eylea 2 mg used for?

Accepted Answer

Eylea 2 mg is used to treat various retinal conditions involving abnormal blood vessel growth. These conditions include neovascular age-related macular degeneration, macular edema secondary to retinal vein occlusion, diabetic macular edema, diabetic retinopathy, and myopic choroidal neovascularization. The medication helps to reduce the growth of abnormal blood vessels and swelling in the retina, thereby preventing vision loss.

Question 2

How does Aflibercept work?

Accepted Answer

Aflibercept, the active ingredient in Eylea 2 mg, is a VEGF inhibitor presented as a 2 mg solution for intravitreal use. It is used to treat various eye conditions involving abnormal blood vessel growth, such as neovascular age-related macular degeneration and diabetic macular edema. GNH USA supplies Eylea 2 mg as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies, and clinics worldwide.

Eylea 2 mg is a biologic medication designed to inhibit vascular endothelial growth factor (VEGF), which plays a crucial role in the formation of new blood vessels. This medication is administered directly into the eye to manage specific retinal conditions.

Question 3

What is the usual dose of Eylea 2 mg?

Accepted Answer

The dosage of Eylea 2 mg is determined by a healthcare professional based on the specific condition being treated and the patient's response to the medication. It is typically administered as an intravitreal injection. The prescriber will set the appropriate dosing regimen, which may vary depending on the individual needs of the patient.

Question 4

Is Eylea 2 mg safe during pregnancy or breastfeeding?

Accepted Answer

The safety of Eylea 2 mg during pregnancy or breastfeeding has not been established. It is important to consult a healthcare provider before using this medication if you are pregnant, planning to become pregnant, or breastfeeding. The healthcare provider will weigh the potential benefits and risks to determine the appropriate course of treatment.

Question 5

How do I order Eylea 2 mg from GNH USA?

Accepted Answer

To order Eylea 2 mg from GNH USA, submit an enquiry on the product page at gnh-usa.com with the required quantity. GNH USA supplies hospitals, pharmacies, and procurement teams across international markets. The team will ask you to confirm your trade or institutional credentials and will reply with pricing, availability, shipping (including cold-chain where relevant), and the necessary import paperwork.

Question 6

How does Eylea 2 mg compare to other treatments for retinal conditions?

Accepted Answer

Eylea 2 mg is one of several treatments available for retinal conditions involving abnormal blood vessel growth. It is often compared to other anti-VEGF therapies such as ranibizumab and bevacizumab. The choice of treatment depends on various factors, including the specific condition, the patient's response to treatment, and the healthcare provider's recommendation. Eylea 2 mg has been shown to be effective in clinical studies and is widely used in the management of retinal diseases.

Question 7

How should Eylea 2 mg be stored and handled?

Accepted Answer

Eylea 2 mg should be stored at 2-8°C, kept refrigerated, and protected from light. It is important not to freeze or shake the medication. Proper storage and handling are crucial to maintain the efficacy and safety of the medication. Always follow the storage instructions provided by the manufacturer and consult a healthcare professional if you have any questions.

Question 8

How is Eylea 2 mg administered?

Accepted Answer

Eylea 2 mg is administered as an intravitreal injection, which means it is injected directly into the eye. This procedure is typically performed by a healthcare professional in a clinical setting. The injection is carefully administered to ensure it reaches the intended area within the eye. The healthcare provider will monitor the patient during and after the injection to ensure safety and effectiveness.

Question 9

What are the most serious risks to watch for with Eylea 2 mg?

Accepted Answer

The most serious risks associated with Eylea 2 mg include endophthalmitis (severe eye infection), retinal detachment, intraocular inflammation, stroke, heart attack, and severe vision loss. Patients should be monitored closely for any signs of these complications. If any serious side effects occur, immediate medical attention should be sought.

Question 10

Who should not use Eylea 2 mg?

Accepted Answer

Eylea 2 mg should not be used by individuals who have a known hypersensitivity to Aflibercept or any of the excipients in the medication. It should also be used with caution in patients with a history of eye infections, inflammation, or other severe eye conditions. Pregnant or breastfeeding women should consult a healthcare provider before using this medication. Always follow the advice of a healthcare professional regarding the use of Eylea 2 mg.